PBIGF
Price
$0.14
Change
+$0.03 (+27.27%)
Updated
Oct 30 closing price
PTCHF
Price
$2.20
Change
+$0.05 (+2.33%)
Updated
Dec 16 closing price
Ad is loading...

PBIGF vs PTCHF

Header iconPBIGF vs PTCHF Comparison
Open Charts PBIGF vs PTCHFBanner chart's image
Paradigm Biopharmaceuticals
Price$0.14
Change+$0.03 (+27.27%)
Volume$30.53K
CapitalizationN/A
PureTech Health
Price$2.20
Change+$0.05 (+2.33%)
Volume$3.2K
CapitalizationN/A
PBIGF vs PTCHF Comparison Chart
Loading...
View a ticker or compare two or three
VS
PBIGF vs. PTCHF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBIGF is a Hold and PTCHF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (PBIGF: $0.14 vs. PTCHF: $2.20)
Brand notoriety: PBIGF and PTCHF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PBIGF: 128% vs. PTCHF: 27%
Market capitalization -- PBIGF: $92.57M vs. PTCHF: $499.06M
PBIGF [@Biotechnology] is valued at $92.57M. PTCHF’s [@Biotechnology] market capitalization is $499.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PBIGF’s FA Score shows that 0 FA rating(s) are green whilePTCHF’s FA Score has 1 green FA rating(s).

  • PBIGF’s FA Score: 0 green, 5 red.
  • PTCHF’s FA Score: 1 green, 4 red.
According to our system of comparison, PTCHF is a better buy in the long-term than PBIGF.

Price Growth

PBIGF (@Biotechnology) experienced а 0.00% price change this week, while PTCHF (@Biotechnology) price change was +2.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.12%. For the same industry, the average monthly price growth was -2.34%, and the average quarterly price growth was -1.61%.

Industries' Descriptions

@Biotechnology (-7.12% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
PTCHF($499M) has a higher market cap than PBIGF($92.6M). PTCHF YTD gains are higher at: -7.563 vs. PBIGF (-48.685).
PBIGFPTCHFPBIGF / PTCHF
Capitalization92.6M499M19%
EBITDAN/AN/A-
Gain YTD-48.685-7.563644%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
PTCHF: Fundamental Ratings
PTCHF
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL248.05-5.43
-2.14%
Apple
SPY586.28-18.01
-2.98%
SPDR® S&P 500® ETF Trust
BTC.X100041.540000-6099.062500
-5.75%
Bitcoin cryptocurrency
TSLA440.13-39.73
-8.28%
Tesla
GME28.55-2.71
-8.67%
GameStop Corp

PBIGF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBIGF has been loosely correlated with ABEO. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PBIGF jumps, then ABEO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBIGF
1D Price
Change %
PBIGF100%
N/A
ABEO - PBIGF
34%
Loosely correlated
-4.25%
STTK - PBIGF
21%
Poorly correlated
-6.09%
ARWR - PBIGF
21%
Poorly correlated
-8.58%
OXBDF - PBIGF
7%
Poorly correlated
N/A
PTCHF - PBIGF
6%
Poorly correlated
N/A
More

PTCHF and

Correlation & Price change

A.I.dvisor tells us that PTCHF and OMGA have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTCHF and OMGA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCHF
1D Price
Change %
PTCHF100%
N/A
OMGA - PTCHF
22%
Poorly correlated
-3.20%
PHGE - PTCHF
22%
Poorly correlated
-6.60%
BCTX - PTCHF
22%
Poorly correlated
-4.58%
ACET - PTCHF
20%
Poorly correlated
-6.28%
SBMFF - PTCHF
18%
Poorly correlated
N/A
More